Panel Discussion: Navigating Strategic Investments by Harnessing Insights from Recent Acquisitions & Collaborations within the LNP Field
9:30 am - Tuesday 7th April 2026
- What are the driving factors behind recent deals, what are the unique aspects of LNP technology that investors are most focused on?
- What key factors do investors evaluate when assessing the potential and risks of LNP technologies?
- Beyond individual drug candidates, how do investors envision the broader potential and future impact of these LNP partnerships?
Speakers:
Director, Strategic Innovation, Global Rare Disease
Chiesi Global Rare Diseases
Managing Director & Ex-Senior Director, Head of Cell Engineering at Capstan
Bluepeak Partner